TOT Biopharm International Co (HKSE:01875) EBIT per Share : HK$0.07 (TTM As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is TOT Biopharm International Co EBIT per Share?

TOT Biopharm International Co's EBIT per Share for the six months ended in Jun. 2024 was HK$0.05. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.07.

During the past 3 years, the average EBIT per Share Growth Rate was 62.40% per year. During the past 5 years, the average EBIT per Share Growth Rate was 45.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for TOT Biopharm International Co's EBIT per Share or its related term are showing as below:

HKSE:01875' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -39.7 Med: 26.35 Max: 62.4
Current: 62.4

During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of TOT Biopharm International Co was 62.40% per year. The lowest was -39.70% per year. And the median was 26.35% per year.

HKSE:01875's 3-Year EBIT Growth Rate is ranked better than
95.23% of 1237 companies
in the Biotechnology industry
Industry Median: 8.1 vs HKSE:01875: 62.40

TOT Biopharm International Co's EBIT for the six months ended in Jun. 2024 was HK$38 Mil.

TOT Biopharm International Co EBIT per Share Historical Data

The historical data trend for TOT Biopharm International Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TOT Biopharm International Co EBIT per Share Chart

TOT Biopharm International Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

Get a 7-Day Free Trial

-0.60

-0.55

-0.08

-0.05

0.07

TOT Biopharm International Co Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EBIT per Share	Get a 7-Day Free Trial									-0.05	-0.02	-0.03	0.05	0.01

TOT Biopharm International Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

TOT Biopharm International Co's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-35.636	/	725.197
=	-0.05

TOT Biopharm International Co's EBIT per Share for the quarter that ended in Jun. 2024 is calculated as

	EBIT per Share		(Q: Jun. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	38.153	/	725.197
=	0.05

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.07

TOT Biopharm International Co (HKSE:01875) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

TOT Biopharm International Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of TOT Biopharm International Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

TOT Biopharm International Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TOT Biopharm International Co Ltd (HKSE:01875) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

120 Changyang Street, Suzhou Industrial Park, Suzhou, CHN, 215024

Website

https://www.totbiopharm.com.cn

TOT Biopharm International Co Ltd is a clinical-stage biopharmaceutical company dedicated to developing and commercializing oncology drugs and therapies for patients and their families as well as medical professionals. It has a pipeline of oncology drug candidates, which include monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs). It generates revenues from Mainland China.

Executives

Center Laboratories, Inc.	2201 Interest of corporation controlled by you
Tricor Trust (hong Kong) Limited	2301 Trustee
Chengwei Evergreen Capital, Lp	2101 Beneficial owner
Center Laboratories Inc.	2101 Beneficial owner
Chengwei Evergreen Management, Llc	2201 Interest of corporation controlled by you
Suzhou Vivo Management Consulting Partnership (limited Partnership)
Vivo (suzhou) Health Industry Investment Fund (limited Partnership)
Vivo Capital Llc
Vivo Capital Viii, Llc
Vivo Capital Fund Viii, L.p.
Prime Success International Limited	2101 Beneficial owner
Advantech Capital Ii L.p.
Advantech Capital Ii Master Investment Limited
Advantech Capital Investment V Limited
Advantech Capital Partners Ii Limited

TOT Biopharm International Co Headlines

No Headlines